SonoThera™ Announces Research Collaboration with Janssen Pharmaceuticals, Inc. to Accelerate Development of Ultrasound-Guided Nonviral Gene Therapy Platform

SonoThera and Janssen Pharmaceuticals, Inc. have entered into a research collaboration agreement to develop a novel approach for delivering nucleic acid-based therapeutics. The research will focus on delivery of next-generation DNA and RNA-based nucleic acid therapeutics to non-liver organ targets and diseases. SonoThera is developing a platform using sonoporation to non-invasively deliver nucleic acid payloads … Read more